Showing results (481-490 of 517) with videos related to

Sort By:
Pageof 52
Elife|September 21, 2021
Impaired mRNA splicing and proteostasis in preadipocytes in obesity-related metabolic diseaseJulia Sánchez-Ceinos, Rocío Guzmán-Ruiz, Oriol Alberto Rangel-Zúñiga, et al.
The Journal of Clinical Endocrinology and Metabolism|August 7, 2021
Dysregulation of Components of the Inflammasome Machinery After Bariatric Surgery: Novel Targets for a Chronic DiseaseVicente Herrero-Aguayo, Prudencio Sáez-Martínez, Juan L López-Cánovas, et al.
The Journal of Endocrinology|September 3, 2016
Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitroAlejandro Ibáñez-Costa, Esther Rivero-Cortés, Mari C Vázquez-Borrego, et al.
Cancer Letters|October 10, 2020
Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinomaJuan L López-Cánovas, Mercedes Del Rio-Moreno, Helena García-Fernandez, et al.
Neuroendocrinology|January 16, 2020
Statins Directly Regulate Pituitary Cell Function and Exert Antitumor Effects in Pituitary TumorsMari C Vázquez-Borrego, Antonio C Fuentes-Fayos, Aura D Herrera-Martínez, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 19, 2012
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammationRiccarda Granata, Davide Gallo, Raul M Luque, et al.
Molecular Cancer|August 31, 2017
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressivenessDaniel Hormaechea-Agulla, Manuel D Gahete, Juan M Jiménez-Vacas, et al.
Molecular Therapy. Nucleic Acids|March 14, 2022
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic toolVicente Herrero-Aguayo, Prudencio Sáez-Martínez, Juan M Jiménez-Vacas, et al.
Molecular Oncology|May 25, 2024
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targetsEmilia Alors-Pérez, Ricardo Blázquez-Encinas, María Trinidad Moreno-Montilla, et al.
Ebiomedicine|March 12, 2023
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidenceAntonio C Fuentes-Fayos, Miguel E G-García, Jesús M Pérez-Gómez, et al.
Pageof 52